Curcumin inhibits EGFR by repressing the expression of genes and proteins in the EGFR-PI3K-AKT pathway, thereby overcoming Lenvatinib’s resistance in hepatocellular carcinoma cells. Here, EGFR is linked to hepatocellular carcinoma.